Therapeutic effect of interferon-γ for prevention of severe infection in X-linked chronic granulomatous disease

Journal of the Formosan Medical Association

Volumn 102, Issue 3, 2003, Pages 189-192

  Ma, Hui Ru ^a   Mu, Shu Chi ^a   Yang, Yao Hsu ^b   Chen, Chung Min ^b   Chiang, Bor Luen ^b  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Chronic granulomatous disease; Interferon gamma, recombinant

Indexed keywords

COTRIMOXAZOLE; GENOMIC DNA; ITRACONAZOLE; NITROBLUE TETRAZOLIUM; RECOMBINANT GAMMA INTERFERON;

ANAMNESIS; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CASE REPORT; CELL ACTIVITY; CHILD DEVELOPMENT; CHILD GROWTH; CHRONIC DIARRHEA; CHRONIC GRANULOMATOUS DISEASE; DISEASE SEVERITY; DNA SEQUENCE; DOSE RESPONSE; DRUG EFFECT; FOLLOW UP; GENETIC ANALYSIS; GRAM NEGATIVE INFECTION; HUMAN; INHERITANCE; KLEBSIELLA PNEUMONIAE; LIVER ABSCESS; MALE; MONOCYTE; NEUTROPHIL; NITROBLUE TETRAZOLIUM TEST; OSTEOMYELITIS; OUTPATIENT CARE; PHAGOCYTE DYSFUNCTION; PLEURA EMPYEMA; PRESCHOOL CHILD; PROPHYLAXIS; RESPIRATORY BURST; SINGLE STRAND CONFORMATION POLYMORPHISM; SKIN ABSCESS; THRUSH; X CHROMOSOME LINKAGE;

ANTIVIRAL AGENTS; ASPERGILLOSIS; CHILD, PRESCHOOL; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; INTERFERON-GAMMA, RECOMBINANT; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LUNG DISEASES, FUNGAL; MALE; TREATMENT OUTCOME;

EID: 0043011395     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Baehner RL, Kunkel LM, Monaco AP, et al: DNA linkage analysis of X chromosome linked chronic granulomatous disease. Proc Natl Acad Sci USA 1986;83:3398-401.
2. Rae J, Newburger PE, Dinauer MC, et al: X linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of the respiratory-burst oxidase. Am J Hum Genet 1998;62:1320-31.
3. Winkelstein JA, Marino MC, Johnston RB Jr et al: Chronic granulomatous disease: report on a national registry of 368 patients. Medicine (Baltimore) 2000;79:155-69.
4. Mouy R, Fisher A, Vilmer E, et al: Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr 1989;114:555-60.
5. Liese J: Long term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr 2000;137:687-93.
6. Baehner RL, Nathan DG: Quantitative nitro blue tetrazolium test in chronic granulomatous disease. N Engl J Med 1968;278:971-6.
7. Lin SJ, Huang YF, Chen JY, et al: Molecular quality control machinery contributes to the leukocyte NADPH oxidase deficiency in chronic granulomatous disease. Biochim Biophys Acta 2002;1586:275-86.
8. De Boer M, Bolscher BG, Sijmons RH, et al: Prenatal diagnosis in a family with X-linked chronic granulomatous disease with the use of the polymerase chain reaction. Prenat Diagn 1992;12:773-7.
9. Johansen KS: Nitroblue tetrazolium slide test. Use of the phorbol-myristate-acetate-stimulated NBT-reduction slide test for routine and prenatal detection of chronic granulomatous disease and diagnosis of heterozygous carriers. Acta Pathol Microbiol Immunol Scand [C] 1983;91:349-54.
10. Pasic S, Abinun M. Pistignjat B, et al: Aspergillus osteomyelitis in chronic granulomatous disease: treatment with recombinant gamma-interferon and itraconzole. Pediatr Inf Dis J 1996;15: 833-4.
11. Gallin JI, Malech HL, Melnick DA, et al: A controlled trial of interferon-gamma to prevent infection in chronic granulomatous disease. N Engl J Med 1991;324:509-16.
12. Dario C, Mirella F, Franco C, et al: Effectiveness of IFN-gamma for liver abscesses in chronic granulomatous disease. J Interferon Cytokine Res 1999;19:705-10.